Deal Intelligence Guides
In-depth resources backed by data from 1,900++ biopharma transactions. Written for BD professionals, licensing teams, and deal committees.
How to Negotiate Pharma Licensing Royalty Rates
Data-backed strategies for structuring and negotiating royalty rates in biopharma licensing deals, with benchmarks from 3,000+ transactions.
Biotech Licensing Deal Structure: Upfront, Milestones & Royalties
Comprehensive breakdown of the three pillars of biopharma licensing economics, with benchmark data and structuring strategies for each component.
Risk-Adjusted NPV (rNPV) for Biotech Valuation
Master the industry-standard rNPV methodology for valuing biotech assets, from phase transition probabilities to Monte Carlo enhancement.
Pharma M&A vs. Licensing: When to Acquire vs. License
Strategic framework for choosing between M&A and licensing in biopharma, with case studies and decision criteria for BD professionals.
Biopharma Licensing Benchmarks 2026: Data From 2,500+ Deals
Comprehensive benchmarks for upfront payments, milestones, and royalties by phase, modality, and therapeutic area — based on 2,500+ disclosed transactions.
Life Sciences Deal Calculator: Benchmark Upfronts, Milestones & Royalties
How to use the Ambrosia deal calculator to model rNPV, Monte Carlo, partner matching, and buyer-specific valuations across 12 TAs and 23+ modalities.
Ready to benchmark?
Model deal terms against 1,900++ transactions across 12 therapeutic areas with 14 calculation engines.
Try the Calculator